A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques. The research offers a new and specific target for the development of drugs that specifically treat cardiovascular complications associated with metabolic syndrome.